Leonteq Securities’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
Other funds holding KYMR
SL
Leonteq Securities's KYMR Position: Q3 2026 in Review
Leonteq Securities held its Kymera Therapeutics (KYMR) position steady in Q3 2026 at 200 shares worth $22.4K. The position accounts for ﹤0.01% of the portfolio, ranked #912.
Leonteq Securities first reported a position in KYMR in Q4 2021 and has held it in 6 quarters since. The position peaked at $247K in Q4 2021. 221 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.
- Leonteq Securities held 200 shares of Kymera Therapeutics worth $22.4K as of Q3 2026.
- Leonteq Securities left its Kymera Therapeutics share count unchanged in Q3 2026.
- Kymera Therapeutics made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #912 holding.
- Leonteq Securities first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 6 quarters since.
- Leonteq Securities's Kymera Therapeutics position peaked at $247K in Q4 2021.
- 221 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.